03:00 PM EDT, 05/22/2026 (MT Newswires) -- Healthcare stocks rose late Friday afternoon, with the NYSE Healthcare Index advancing 1.1% and the State Street Health Care Select Sector SPDR ETF (XLV) adding 1.3%.

The iShares Biotechnology ETF (IBB) was fractionally higher.

In corporate news, Gilead Sciences ( GILD ) shares gained 2.9%. The company has received approval from the US Food and Drug Administration for Hepcludex to treat chronic hepatitis delta virus infection in adults without advanced liver scarring, or with compensated cirrhosis, the FDA said Friday.